Consumer Tech (Nov 16-20): Anthropic Makes A Smashing Debut, GTA 6 Releases & More
Trump reportedly urges Europe to stop funding Ukraine, while his administration approves nearly 900,000 Nvidia and AMD AI chips for Chinese companies.
Follow the latest DataMeds AI, Inc. (MEDS) news and market headlines alongside the live MEDS price. Stay informed on what's moving MEDS.
Trump reportedly urges Europe to stop funding Ukraine, while his administration approves nearly 900,000 Nvidia and AMD AI chips for Chinese companies.
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 16.4% to $3.82 during Friday's after-market session. The market value of their outstanding shares is at $16.1 million. Spectral AI (NASDAQ:MDAI)
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 44.3% to $1.05 during Friday's regular session. The market value of their outstanding shares is at $4.1 million. Akanda (NASDAQ:AKAN) stock moved upwards by
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 48.4% to $1.08 during Friday's pre-market session. The company's market cap stands at $4.1 million. Akanda (NASDAQ:AKAN) stock increased by 31.63% to
Gap shares rise 3.8% after Q3 EPS beat estimates; Athleta names new CEO. Erayak and NewGenIvf lead gainers, Solmate leads losers.
DataMeds AI shares surged 55.28% in after-hours after announcing an acquisition deal for cancer diagnostics assets from Todos Medical.
CLIA-Certified Cancer Diagnostics Laboratory Will Acquire Spectroscopy Platform to Support Machine Learning Expansion into Additional Cancer TypesCE Marks previously held in Europe for breast cancer and colorectal
Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose 47.7% to $4.18.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to MEDS, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.